Category :

Warning of dextromethorphan abuse

Warning of dextromethorphan abuse

The AMK warns against the abuse of dextromethorphan. The centrally active antitussive was most frequently reported to the AMK with suspected abuse in the last six years.

Anticoagulation May Improve COVID-19 Prognosis

Anticoagulation May Improve COVID-19 Prognosis

In patients at the New York Mount Sinai Health Systems clinics, there was a significant reduction in the number of in-hospital patients undergoing anticoagulation therapy in patients requiring ventilation compared to COVID-19 patients who were not treated with anticoagulants

New D-A-CH reference values ​​for vitamin A intake

New D-A-CH reference values ​​for vitamin A intake

The German Nutrition Society e. V. (DGE) has revised the reference values ​​for vitamin A intake together with the nutrition companies from Austria and Switzerland.

Corona virus also causes skin symptoms

Corona virus also causes skin symptoms

An infection with the corona virus COVID-19 can not only cause lung symptoms, but can also be noticeable with skin changes. About every fifth COVID-19 patient who is treated as an inpatient develop efflorescences such as skin r

Popular Posts

Indications for podiatry regulation expanded

Indications for podiatry regulation expanded

In order to avoid consequential damage to the feet, doctors can prescribe podiatry therapy as a remedy for pathological damage to the foot as a result of sensitive or sensorimotor neuropathy or as a result of a paraplegic syndrome.....

What therapy for locally advanced colon cancer?

What therapy for locally advanced colon cancer?

A systematic review with meta-analysis shows that neoadjuvant therapy is a promising therapeutic approach for locally advanced colorectal cancer. It is superior to standard therapy in terms of pathological response.

New Medicines May 1, 2020

New Medicines May 1, 2020

As of May 1, 2020, over 120 products were registered for the German market, including Nubeqa for the treatment of prostate cancer, Prevenar IQ pre-filled syringes and various Cinacalcet generics.

Tofacitinib - EU approval recommendation for rheumatoid arthritis

Tofacitinib - EU approval recommendation for rheumatoid arthritis

Tofacitinib received the European approval recommendation from the CHMP Committee for Medicinal Products for Human Use in January 2017. After successful approval, rheumatism patients in Germany could now also benefit from the JAK inhibitor.

Re-launch of the Rekovelle

Re-launch of the Rekovelle

On February 15, 2017, the new drug Rekovelle (Follitropin delta) for the treatment of female infertility will be launched on the market.

Editor'S Choice 2021

Kidney stones

Kidney stones

In Germany around 5% of the population are affected by kidney stones (nephrolites). They are crystalline deposits. A distinction is made between kidney and ureter stones. Sharp, wavy pains are symptomatic and often radiate to the back....

Interesting Articles